{"meta":{"query_hash":"a3226bd3ac50","filters":{"venue":"Clinical Medicine Insights Oncology"},"cohort_total":14,"direct_labels_cover":0,"predictions_cover":14,"exported":14,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/a3226bd3ac50","api":"https://metacan.xera.ac/api/v1/cohort?venue=Clinical+Medicine+Insights+Oncology"},"results":[{"id":"W1975700525","doi":"10.4137/cmo.s12811","title":"Comparing the Performance of Hybrid Capture II and Polymerase Chain Reaction (PCR) for the Identification of Cervical Dysplasia in the Screening and Diagnostic Settings","year":2013,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; BC Cancer Agency","keywords":"Concordance; Dysplasia; Internal medicine; Predictive value; Polymerase chain reaction; Medicine; Squamous intraepithelial lesion; Gastroenterology; Gynecology; Oncology; Obstetrics; Biology; Cervical intraepithelial neoplasia; Cervical cancer; Cancer; Genetics; Gene","score_opus":0.07016592254959536,"score_gpt":0.3929333716555729,"score_spread":0.32276744910597754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975700525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885101,0.0047726785,0.004787937,0.00011800332,0.000050481114,0.00009281711,0.00020355612,0.000059209513,0.0014053471],"genre_scores_gemma":[0.9954679,0.0005394836,0.0032992393,0.00007998738,0.000034478642,0.000043677126,0.000281572,0.000006792511,0.00024678838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900181,0.005480512,0.00048396582,0.0016490687,0.0020132607,0.0003549601],"domain_scores_gemma":[0.98284817,0.012182967,0.0020177055,0.000574623,0.0019412504,0.00043528684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009208786,0.0006845216,0.00048146473,0.0017354888,0.0002098955,0.00084053364,0.0005306023,0.00087176135,0.0005842218],"category_scores_gemma":[0.021921994,0.00045494456,0.0005344661,0.00064863346,0.0007724771,0.0004464526,0.0004597181,0.00054710085,0.0002662158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016333238,0.00009617743,0.9686451,0.00018518648,0.0005047514,0.000074759475,0.0003810619,0.0005007503,0.0067807785,0.00005925286,0.00015644955,0.020982316],"study_design_scores_gemma":[0.0000924506,0.0043669036,0.9746181,0.00008542133,0.0003570988,0.0013299817,0.00043045386,0.006229368,0.011642734,0.0001396531,0.00066586916,0.000042067328],"about_ca_topic_score_codex":0.0031706006,"about_ca_topic_score_gemma":0.003921488,"teacher_disagreement_score":0.009208786,"about_ca_system_score_codex":0.00066337764,"about_ca_system_score_gemma":0.00046522258,"threshold_uncertainty_score":0.048701286},"labels":[],"label_agreement":null},{"id":"W1998810794","doi":"10.4137/cmo.s7658","title":"Antitumor Efficacy of Intravesical BCG, Gemcitabine, Interferon-α and Interleukin-2 as Mono- or Combination-Therapy for Bladder Cancer in an Orthotopic Tumor Model","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Cancer Institute","keywords":"Gemcitabine; Medicine; Bladder cancer; Urology; Combination therapy; Internal medicine; Cancer; Oncology","score_opus":0.1626714718544074,"score_gpt":0.4567886025966603,"score_spread":0.29411713074225293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998810794","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966536,0.0020179125,0.0005925796,0.000040576833,0.000028794751,0.000033995617,0.000064457556,0.000040414285,0.0005277581],"genre_scores_gemma":[0.9965373,0.0010961726,0.0012176089,0.000018735165,0.000022503566,0.000043749285,0.00013197036,0.000006923456,0.0009250178],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99988997,0.000026220707,0.000009601354,0.000021287724,0.000026449781,0.000026412928],"domain_scores_gemma":[0.99991035,0.000011978289,0.00002594929,0.000012813773,0.0000065683453,0.000032278156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002500277,0.0004017789,0.000482922,0.00038149135,0.000087008506,0.00022302328,0.00024859532,0.00023391914,0.000738727],"category_scores_gemma":[0.00008766754,0.000102975966,0.00021621477,0.00021553677,0.00019538664,0.00017599862,0.00012444552,0.00047746117,0.00015334086],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037568342,0.0015755844,0.0010513858,0.00016451147,0.000048563037,0.00006113179,0.00003352766,0.0005376748,0.97639626,0.00007147923,0.00011647989,0.01618663],"study_design_scores_gemma":[0.0005938292,0.043735594,0.011212708,0.000028698903,0.0002280666,0.0004770657,0.00004042226,0.002302496,0.93865997,0.000044280878,0.002662914,0.000013971425],"about_ca_topic_score_codex":0.00024480632,"about_ca_topic_score_gemma":0.0006726858,"teacher_disagreement_score":0.000738727,"about_ca_system_score_codex":0.00015701889,"about_ca_system_score_gemma":0.00021775487,"threshold_uncertainty_score":0.0024713278},"labels":[],"label_agreement":null},{"id":"W2013612418","doi":"10.4137/cmo.s4259","title":"Imatinib Mesylate: Past Successes and Future Challenges in the Treatment of Gastrointestinal Stromal Tumors","year":2011,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Gastrointestinal Tumor Research and Treatment","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; Island Health","funders":"","keywords":"Imatinib mesylate; GiST; Imatinib; Medicine; PDGFRA; Tyrosine-kinase inhibitor; Oncology; Targeted therapy; Internal medicine; Adverse effect; Tyrosine kinase; Stromal tumor; Cancer research; Stromal cell; Gastroenterology; Receptor; Cancer","score_opus":0.19490410281532752,"score_gpt":0.4203636887698943,"score_spread":0.22545958595456675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013612418","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006207161,0.9635296,0.00055407063,0.027291473,0.00038283117,0.0000070236533,0.000031531043,0.000031286112,0.0019651407],"genre_scores_gemma":[0.061049663,0.92504156,0.0021262786,0.0063655274,0.003774291,0.000028535414,0.00006465322,0.000028421997,0.0015210204],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988405,0.00036315402,0.00021999577,0.0001624858,0.00028990742,0.00012384726],"domain_scores_gemma":[0.9968362,0.0017544122,0.00043366372,0.000102391255,0.00041592427,0.0004574421],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0091152005,0.0005930083,0.001312019,0.0012560317,0.0005369633,0.002364408,0.00076565734,0.0019128862,0.0028194017],"category_scores_gemma":[0.0047391276,0.0002922598,0.00044264257,0.0014953577,0.0030076455,0.0049994155,0.0014635685,0.0038167615,0.0012287216],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092798006,0.0002193263,0.0024276485,0.0021040612,0.00008763139,0.00053758867,0.0002498928,0.00081232784,0.0020441345,0.008341695,0.0159578,0.9662899],"study_design_scores_gemma":[0.0005871141,0.0052394397,0.017995525,0.0042305263,0.000452065,0.0061540087,0.0016015263,0.0033348228,0.0047477414,0.03094349,0.92450583,0.00020794217],"about_ca_topic_score_codex":0.00043410546,"about_ca_topic_score_gemma":0.0023189897,"teacher_disagreement_score":0.0091152005,"about_ca_system_score_codex":0.0011028722,"about_ca_system_score_gemma":0.00095282204,"threshold_uncertainty_score":0.04820639},"labels":[],"label_agreement":null},{"id":"W2019669516","doi":"10.4137/cmo.s6460","title":"Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations","year":2012,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre","funders":"","keywords":"Trastuzumab; Metastatic breast cancer; Breast cancer; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.2429678331864455,"score_gpt":0.5547950459468237,"score_spread":0.3118272127603782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019669516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008038702,0.49283502,0.004751987,0.45942628,0.0017291276,0.00011378553,0.00018930365,0.00003865776,0.032877196],"genre_scores_gemma":[0.17885137,0.72274417,0.009829286,0.06185924,0.014547053,0.00027850224,0.00024488082,0.0000438157,0.011601794],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976839,0.0011428333,0.00016307946,0.00010676954,0.0007871353,0.00011639724],"domain_scores_gemma":[0.9927527,0.004728697,0.0007599139,0.000110325345,0.0010209355,0.00062742183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005741366,0.0004581864,0.00088340737,0.0009619174,0.00041002687,0.0032249603,0.0009160963,0.0038694332,0.008585145],"category_scores_gemma":[0.012841314,0.00016155074,0.00042210994,0.0010904819,0.0013362481,0.0027667827,0.0008818397,0.0035725827,0.0012525419],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083978125,0.0002410853,0.0016724187,0.0028127902,0.00014222841,0.002106298,0.00014011766,0.0037517908,0.0021957152,0.08507012,0.095000185,0.80602753],"study_design_scores_gemma":[0.0007504464,0.0013400103,0.0070466097,0.008973295,0.0002763654,0.009858926,0.00076731725,0.0046930932,0.0014599806,0.13860038,0.82610905,0.00012448049],"about_ca_topic_score_codex":0.001042675,"about_ca_topic_score_gemma":0.0023934257,"teacher_disagreement_score":0.008585145,"about_ca_system_score_codex":0.0018644441,"about_ca_system_score_gemma":0.003829299,"threshold_uncertainty_score":0.03036362},"labels":[],"label_agreement":null},{"id":"W2329997776","doi":"10.4137/cmo.s32813","title":"Hormone Receptors in Serous Ovarian Carcinoma: Prognosis, Pathogenesis, and Treatment Considerations","year":2016,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Sault Area Hospital","funders":"","keywords":"Ovarian cancer; Tamoxifen; Medicine; Hormone; Estrogen receptor; Ovarian carcinoma; Hormone receptor; Oncology; Internal medicine; Serous fluid; Cancer; Breast cancer; Estrogen; Gynecology; Bioinformatics; Biology","score_opus":0.1605716960928768,"score_gpt":0.4398224549734831,"score_spread":0.2792507588806063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329997776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000057815185,0.99926955,0.00003376265,0.00027756477,0.00009556725,0.0000010279763,0.000005891561,0.000001726505,0.00025705848],"genre_scores_gemma":[0.00059839577,0.9987895,0.00006439781,0.00012714133,0.00021577984,0.0000016275633,0.000011579305,4.642197e-7,0.00019110035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998419,0.000034462773,0.00003220876,0.00002455188,0.00005273893,0.0000141568],"domain_scores_gemma":[0.99965405,0.00017792398,0.00004944433,0.000009365277,0.00008812396,0.0000211858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054168724,0.000537145,0.0011160668,0.0018275742,0.00022722247,0.00078720826,0.0006396421,0.0008497981,0.0016933163],"category_scores_gemma":[0.0009507087,0.00017521567,0.00039335707,0.0017253853,0.00050205237,0.00107916,0.00042780105,0.0016570891,0.00091406354],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073621486,0.000044919612,0.00064708956,0.011119196,0.00006876507,0.0004259932,0.000074748554,0.0003272751,0.00075084675,0.0031521474,0.027880087,0.9554354],"study_design_scores_gemma":[0.000021466949,0.00014351077,0.0029448073,0.008907359,0.00022119601,0.007660473,0.00021214636,0.00016640381,0.00036908657,0.0039526313,0.9753668,0.000034122182],"about_ca_topic_score_codex":0.0011588664,"about_ca_topic_score_gemma":0.0019577667,"teacher_disagreement_score":0.0018275742,"about_ca_system_score_codex":0.0004778666,"about_ca_system_score_gemma":0.0007194583,"threshold_uncertainty_score":0.005664706},"labels":[],"label_agreement":null},{"id":"W2517906931","doi":"10.4137/cmo.s40479","title":"Monitoring Metastasis and Cachexia in a Patient with Breast Cancer: A Case Study","year":2016,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Columbia College","funders":"National Center for Advancing Translational Sciences; National Cancer Institute","keywords":"Medicine; Cachexia; Breast cancer; Wasting; Metastasis; Metastatic breast cancer; Cancer; Oncology; Internal medicine; Weight loss; Obesity","score_opus":0.1574341368807754,"score_gpt":0.49482055070780095,"score_spread":0.33738641382702556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2517906931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857265,0.004622192,0.0021564465,0.0025125945,0.00020120459,0.00016006114,0.00014787953,0.00006727148,0.0044059358],"genre_scores_gemma":[0.9947573,0.002081497,0.001127693,0.00071289827,0.0005408901,0.000026653124,0.000085309846,0.00001889858,0.0006489452],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.9993893,0.00009352539,0.000081593746,0.00014072438,0.00010611124,0.00018868304],"domain_scores_gemma":[0.9983724,0.00046868663,0.0003562735,0.00011287691,0.00015816328,0.0005315618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043518792,0.0013748221,0.0011118811,0.0025063204,0.002691165,0.0014002401,0.0010590622,0.003943981,0.0015203846],"category_scores_gemma":[0.0042334604,0.00094995945,0.0012432981,0.0015548303,0.0012836336,0.0015409609,0.0011279597,0.002799766,0.0006087431],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005207517,0.00011674051,0.03251738,0.0000524805,0.000016911881,0.96392775,0.00058626715,0.00007246385,0.0006916528,0.00010161064,0.0002924524,0.0015722521],"study_design_scores_gemma":[0.0000083400955,0.00012033407,0.010578296,0.000022926484,0.000021241642,0.98783827,0.00029147783,0.00024652338,0.00028205963,0.00007436786,0.00049911346,0.000017040491],"about_ca_topic_score_codex":0.003653844,"about_ca_topic_score_gemma":0.003759471,"teacher_disagreement_score":0.003943981,"about_ca_system_score_codex":0.001105802,"about_ca_system_score_gemma":0.0006406622,"threshold_uncertainty_score":0.008023202},"labels":[],"label_agreement":null},{"id":"W2593911674","doi":"10.1177/1179554917691266","title":"Understanding Women’s Choice of Mastectomy Versus Breast Conserving Therapy in Early-Stage Breast Cancer","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Saskatchewan","funders":"Saskatchewan Cancer Agency","keywords":"Breast cancer; Mastectomy; Worry; Thematic analysis; Qualitative research; Medicine; Psychology; Cancer; Internal medicine; Sociology","score_opus":0.21984703430698485,"score_gpt":0.44157666264490986,"score_spread":0.221729628337925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2593911674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799326,0.0012228257,0.00069000793,0.013515873,0.00005750856,0.000041887874,0.00006332558,0.00000443675,0.0044715162],"genre_scores_gemma":[0.9970018,0.00086392026,0.00047429957,0.0010646653,0.000008204972,0.000032160395,0.000016987646,0.0000036625017,0.00053429074],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99399996,0.0047030556,0.00018827412,0.00017467914,0.0004172987,0.00051673356],"domain_scores_gemma":[0.98599017,0.011497933,0.0010847106,0.00011277306,0.000692695,0.0006217034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010220418,0.00024623686,0.00031273297,0.0006247697,0.0027338488,0.0027217476,0.0010050616,0.0010855569,0.0018363267],"category_scores_gemma":[0.019185646,0.00035171444,0.00028558873,0.0008182122,0.00484099,0.0021285769,0.0021315587,0.001580836,0.000107203894],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019629544,0.00007829628,0.03468527,0.00047163753,0.000035799196,0.0011299287,0.9403498,0.00015827057,0.0011058961,0.0034500838,0.0013251883,0.017013395],"study_design_scores_gemma":[0.000016094156,0.0000503999,0.013866189,0.00037663136,0.000020382615,0.0002883125,0.9779227,0.00017268215,0.00025107883,0.0012108263,0.005804643,0.000020072699],"about_ca_topic_score_codex":0.063172884,"about_ca_topic_score_gemma":0.098961174,"teacher_disagreement_score":0.063172884,"about_ca_system_score_codex":0.008307493,"about_ca_system_score_gemma":0.011010845,"threshold_uncertainty_score":0.12561035},"labels":[],"label_agreement":null},{"id":"W2601228975","doi":"10.1177/1179554917698461","title":"Does Motion Assessment With 4-Dimensional Computed Tomographic Imaging for Non–Small Cell Lung Cancer Radiotherapy Improve Target Volume Coverage?","year":2017,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Manitoba; CancerCare Manitoba","funders":"CancerCare Manitoba Foundation","keywords":"Radiation therapy; Nuclear medicine; Medicine; Radiation treatment planning; Lung cancer; Breathing; Volume (thermodynamics); Margin (machine learning); Radiology; Computer science; Physics; Pathology","score_opus":0.015686181959514267,"score_gpt":0.3814454330483923,"score_spread":0.365759251088878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2601228975","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822807,0.0083997585,0.0067355842,0.0014179279,0.00010687699,0.00008022271,0.00012678976,0.000050968545,0.0008011889],"genre_scores_gemma":[0.9957071,0.001223608,0.0026575413,0.00011333221,0.000055278393,0.000017977476,0.00008826237,0.000011654428,0.00012527277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994887,0.00028483043,0.000049259335,0.000048180787,0.00010023923,0.000028843853],"domain_scores_gemma":[0.9987803,0.00059069815,0.00037228124,0.00007580803,0.0001230987,0.000057740715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020433278,0.00034766534,0.00034819756,0.0003727045,0.00010921398,0.00049140205,0.0003995786,0.00053476397,0.000677754],"category_scores_gemma":[0.008935556,0.00017503381,0.00038905084,0.00023859381,0.00033890767,0.0005567722,0.00018233183,0.00017218268,0.00018815786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050303144,0.00046003977,0.5305186,0.000595929,0.00043501204,0.00037594305,0.00023407338,0.010429927,0.034441326,0.00030010994,0.0012445399,0.41593418],"study_design_scores_gemma":[0.0005918391,0.00819614,0.8698398,0.00028396043,0.0011776772,0.002283884,0.0002530708,0.066089235,0.042917117,0.0008450363,0.0073958235,0.00012641556],"about_ca_topic_score_codex":0.0008632372,"about_ca_topic_score_gemma":0.0018960689,"teacher_disagreement_score":0.0020433278,"about_ca_system_score_codex":0.00033081122,"about_ca_system_score_gemma":0.00038383662,"threshold_uncertainty_score":0.0108062625},"labels":[],"label_agreement":null},{"id":"W2807016910","doi":"10.1177/1179554918779581","title":"Precision Medicine in Head and Neck Cancer: Myth or Reality?","year":2018,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Head and neck squamous-cell carcinoma; Head and neck cancer; Precision medicine; Personalized medicine; Clinical trial; Medicine; Cancer; Medical physics; Bioinformatics; Internal medicine; Biology; Pathology","score_opus":0.19754686613586656,"score_gpt":0.5213579928452671,"score_spread":0.3238111267094005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807016910","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0020696984,0.44953072,0.01454225,0.52215326,0.0058349557,0.000027976417,0.00020825444,0.0001568354,0.0054760496],"genre_scores_gemma":[0.1116214,0.67132765,0.02965415,0.1596383,0.024166947,0.00021100891,0.00031034497,0.00012859081,0.0029415663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99184,0.0042020394,0.00051160646,0.00089220563,0.0020859027,0.0004682455],"domain_scores_gemma":[0.9582392,0.03088808,0.0016490269,0.0034638788,0.0039998484,0.0017600585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.033913862,0.0008827939,0.0030678369,0.0016184001,0.0020253148,0.008296905,0.0024062262,0.0061141374,0.004760863],"category_scores_gemma":[0.029067703,0.00043219808,0.0011641347,0.0014267042,0.01884101,0.017213939,0.0049172323,0.012927285,0.0013505046],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005805933,0.00021647796,0.004106073,0.0073809586,0.0005790229,0.0005999546,0.0019655486,0.0023298678,0.0028559277,0.37183508,0.13378893,0.47376147],"study_design_scores_gemma":[0.00011618632,0.0005741718,0.0022676126,0.0059296405,0.00020863219,0.0011033021,0.0022608745,0.0012317584,0.001335723,0.60832226,0.37647927,0.00017059855],"about_ca_topic_score_codex":0.002059995,"about_ca_topic_score_gemma":0.0025644652,"teacher_disagreement_score":0.033913862,"about_ca_system_score_codex":0.003758812,"about_ca_system_score_gemma":0.00765625,"threshold_uncertainty_score":0.1793558},"labels":[],"label_agreement":null},{"id":"W2914100918","doi":"10.1177/1179554919829500","title":"Access to Palliative Care for Cancer Patients Living in a Northern and Rural Environment in Ontario, Canada: The Effects of Geographic Region and Rurality on End-of-Life Care in a Population-Based Decedent Cancer Cohort","year":2019,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Partnership Against Cancer; Cancer Care Ontario; Ontario Stroke Network; Northeast Cancer Centre; NOSM University; Laurentian University; Health Sciences North","funders":"Canadian Institutes of Health Research; Ontario Institute for Cancer Research; Ontario Ministry of Health and Long-Term Care; Government of Ontario; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","keywords":"Rurality; Palliative care; End-of-life care; Medicine; Rural area; Population; Odds ratio; Family medicine; Gerontology; Nursing; Environmental health","score_opus":0.08054192620698813,"score_gpt":0.4237900307381516,"score_spread":0.34324810453116344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914100918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963805,0.000528978,0.000062015875,0.00033134755,0.000007735432,0.000027456566,0.0018929637,0.0000044464414,0.0007646076],"genre_scores_gemma":[0.9982699,0.00032368407,0.000067657835,0.000076024786,0.0000042413208,0.000016137197,0.000750564,0.0000027768401,0.00048891647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993111,0.000056132973,0.000045272955,0.00013620326,0.00018910601,0.0002623112],"domain_scores_gemma":[0.9981927,0.000085563006,0.00059906056,0.00007115863,0.00051714596,0.00053440634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050432415,0.00029624449,0.00040080206,0.0006431264,0.0021523917,0.0010733283,0.0010343347,0.0003169272,0.0016368343],"category_scores_gemma":[0.0018047205,0.0003103166,0.0006617737,0.002096234,0.0007021791,0.00042337895,0.0009895171,0.00062398723,0.00015331499],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036643578,0.00001615156,0.99735343,0.00002353162,0.000038589922,0.000064342894,0.0008787819,0.000035833393,0.00007461315,0.000029447592,0.00044509617,0.0010036095],"study_design_scores_gemma":[0.000005117962,0.000015467098,0.99798334,0.000022464763,0.000018426954,0.00004982913,0.0014404375,0.000103484555,0.00001232505,0.000012765098,0.00033172805,0.000004514109],"about_ca_topic_score_codex":0.9890576,"about_ca_topic_score_gemma":0.99378586,"teacher_disagreement_score":0.014061816,"about_ca_system_score_codex":0.014061816,"about_ca_system_score_gemma":0.017066734,"threshold_uncertainty_score":0.102026105},"labels":[],"label_agreement":null},{"id":"W3131909373","doi":"10.1177/1179554921993069","title":"The Oncolytic Activity of Myxoma Virus against Soft Tissue Sarcoma Is Mediated by the Overexpression of Ribonucleotide Reductase","year":2021,"lang":"en","type":"article","venue":"Clinical Medicine Insights Oncology","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"NIH Clinical Center; National Cancer Institute","keywords":"Oncolytic virus; Myxoma virus; Biology; Soft tissue sarcoma; Gene silencing; Cancer research; Virology; Cell culture; Ribonucleotide reductase; Virus; Sarcoma; Gene; Pathology; Medicine","score_opus":0.044721070711315675,"score_gpt":0.40633089908749215,"score_spread":0.3616098283761765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131909373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965275,0.0013778292,0.0014381374,0.000024509378,0.000008175627,0.000014210395,0.00007540757,0.000021724794,0.0005124378],"genre_scores_gemma":[0.9969451,0.0004638986,0.0017390369,0.000008599765,0.0000034876196,0.000017286495,0.00022205221,0.0000038138994,0.0005968828],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99985814,0.00002989758,0.00001625314,0.00002876577,0.000045209184,0.000021827254],"domain_scores_gemma":[0.999925,0.000021552214,0.000023789058,0.0000103808625,0.000009733669,0.000009432235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022547437,0.0002752799,0.00016981264,0.00014709462,0.00008024602,0.00022332968,0.00012036007,0.00018320807,0.0006033165],"category_scores_gemma":[0.00014294847,0.00009943281,0.00018850228,0.000083552506,0.00019104035,0.00014718271,0.00015390498,0.00032162783,0.00014770446],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003602655,0.000012299876,0.00019456368,0.000018423896,0.0000033535136,0.000009766976,0.000004745106,0.000028069735,0.9991604,0.00003018237,0.000007781611,0.0004943761],"study_design_scores_gemma":[0.000009633466,0.00038597992,0.0028503304,0.0000036415224,0.000010906969,0.00016330392,0.0000067718,0.0006455319,0.99529123,0.000012185811,0.0006188605,0.0000017329617],"about_ca_topic_score_codex":0.00024089516,"about_ca_topic_score_gemma":0.00028604106,"teacher_disagreement_score":0.0006033165,"about_ca_system_score_codex":0.00020430169,"about_ca_system_score_gemma":0.00011650533,"threshold_uncertainty_score":0.0020182729},"labels":[],"label_agreement":null},{"id":"W4210649172","doi":"10.1177/11795549211036898","title":"Radiation-Induced Fibrosis in Patients with Head and Neck Cancer: A Review of Pathogenesis and Clinical Outcomes","year":2022,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Head and neck cancer; Etiology; Radiation therapy; Presentation (obstetrics); Head and neck; Intensive care medicine; Cancer; Pathogenesis; Bioinformatics; Oncology; Internal medicine; Surgery","score_opus":0.1627734475307797,"score_gpt":0.49380680224531975,"score_spread":0.33103335471454004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210649172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012325917,0.99949133,0.000024700264,0.000092836075,0.000042259246,0.0000029961163,0.000022575116,0.000001823853,0.0001983113],"genre_scores_gemma":[0.0007360621,0.9990004,0.000065781234,0.000066849396,0.000045894332,0.0000036114595,0.000023520855,5.089617e-7,0.00005745459],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997098,0.00006151178,0.0000851211,0.00004645509,0.00007837117,0.000018681834],"domain_scores_gemma":[0.9991997,0.0005243721,0.00013333316,0.00001044383,0.0001107909,0.000021393429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006942267,0.00056620233,0.0012797803,0.002276062,0.00025068986,0.00082021847,0.00058656046,0.0005877782,0.0022919746],"category_scores_gemma":[0.0018153103,0.0002057224,0.0008878122,0.0022083814,0.0002961609,0.00088353065,0.00045557812,0.0007903211,0.00038208842],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014718076,0.00005932904,0.001953974,0.09228487,0.0005190381,0.0003063929,0.00017526788,0.0002771236,0.00074766163,0.0012741656,0.020330397,0.88192457],"study_design_scores_gemma":[0.00006204998,0.0004762469,0.01707733,0.1196565,0.003321857,0.0100122765,0.0005602443,0.00023961933,0.00083212747,0.002733651,0.8449339,0.000094219264],"about_ca_topic_score_codex":0.0015032422,"about_ca_topic_score_gemma":0.0032150934,"teacher_disagreement_score":0.0022919746,"about_ca_system_score_codex":0.00043105445,"about_ca_system_score_gemma":0.0012117184,"threshold_uncertainty_score":0.0076674223},"labels":[],"label_agreement":null},{"id":"W4385476635","doi":"10.1177/11795549231187264","title":"Mirvetuximab Soravtansine in Platinum-Resistant Ovarian Cancer","year":2023,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Ovarian cancer; Medicine; Monoclonal antibody; Oncology; Cancer; Chemotherapy; Cytotoxic T cell; Internal medicine; Drug resistance; Antibody; Immunology; Cancer research; Biology; In vitro","score_opus":0.3221679591626192,"score_gpt":0.5417869366401211,"score_spread":0.21961897747750192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385476635","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00026425283,0.9984604,0.00006617053,0.0001603571,0.00008439159,0.0000057766742,0.000020975118,0.0000069244834,0.000930732],"genre_scores_gemma":[0.0014483004,0.9976163,0.00010608727,0.00015662855,0.00006006222,0.000005831573,0.000039558567,0.0000012602488,0.00056593074],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99990714,0.000017339062,0.000017176684,0.000015195104,0.000034317494,0.0000087698045],"domain_scores_gemma":[0.9998884,0.000049709135,0.000021727208,0.0000028061684,0.000027347547,0.000010059516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026452873,0.00035492427,0.0007837636,0.0013215345,0.0001441276,0.0005473911,0.00037762368,0.0004624808,0.0034351465],"category_scores_gemma":[0.00037705823,0.00015285955,0.00043862956,0.0010184136,0.0001513568,0.0005217628,0.00039708288,0.0008618125,0.001141793],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010910751,0.00005584685,0.00016030027,0.02180849,0.00011654733,0.00015251097,0.000050843504,0.00024985484,0.0016509589,0.0013169999,0.016444981,0.9578836],"study_design_scores_gemma":[0.00004377852,0.00018850711,0.0010423599,0.0053376127,0.0002467374,0.0014542417,0.00003731745,0.00012222881,0.00073279435,0.00087291497,0.9899092,0.000012396452],"about_ca_topic_score_codex":0.00073911535,"about_ca_topic_score_gemma":0.0019430779,"teacher_disagreement_score":0.0034351465,"about_ca_system_score_codex":0.0003219739,"about_ca_system_score_gemma":0.0005716373,"threshold_uncertainty_score":0.011491656},"labels":[],"label_agreement":null},{"id":"W4406102421","doi":"10.1177/11795549241311408","title":"Adaptive Treatment of Metastatic Prostate Cancer Using Generative Artificial Intelligence","year":2025,"lang":"en","type":"review","venue":"Clinical Medicine Insights Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"Toronto Metropolitan University","keywords":"Prostate cancer; Medicine; Metastasis; Cancer; Radiation therapy; Clinical trial; Androgen deprivation therapy; Oncology; Disease; Internal medicine","score_opus":0.5304426451892652,"score_gpt":0.598056034547892,"score_spread":0.06761338935862682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406102421","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00036867723,0.9968746,0.0006984561,0.0001849417,0.00009290446,0.000013504538,0.000013921172,0.000011613252,0.0017412929],"genre_scores_gemma":[0.0055023986,0.9925845,0.0009337718,0.00021136615,0.00007353125,0.000020661138,0.00003877538,0.0000044592084,0.0006304889],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99981755,0.00006537718,0.000021091406,0.000026499296,0.000057039415,0.000012393181],"domain_scores_gemma":[0.99976665,0.00017495218,0.000022782002,0.0000081721255,0.000020700681,0.000006711394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040251153,0.00059473526,0.00089991145,0.0010878734,0.00014966606,0.0006753805,0.00080979406,0.0008607838,0.0024326132],"category_scores_gemma":[0.00079790904,0.00019964174,0.00090158853,0.0007691141,0.0003250625,0.000554444,0.00052860053,0.0012232122,0.00068245275],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007317819,0.000071953174,0.0001380615,0.023931636,0.0002715044,0.0001574515,0.00008410229,0.002184462,0.0013386455,0.0072378702,0.006803193,0.95770794],"study_design_scores_gemma":[0.000076279655,0.00041370318,0.0017840669,0.013972814,0.0006470095,0.0028845228,0.00013207436,0.0020289717,0.0028041454,0.010817287,0.96437854,0.000060584996],"about_ca_topic_score_codex":0.0012204668,"about_ca_topic_score_gemma":0.0018536742,"teacher_disagreement_score":0.0024326132,"about_ca_system_score_codex":0.0004481654,"about_ca_system_score_gemma":0.0005586924,"threshold_uncertainty_score":0.008137882},"labels":[],"label_agreement":null}]}